Position
Fidelity in Rigel Pharmaceuticals Inc
Back to the book · All holders of RIGL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $966.1K$27.04 → $39.12
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 67.8K | $2.91M | — | — | — | 0.0% |
| Q1 2026 | 80K | $2.16M | $27.04 | −$1.07M | $328.1K | 0.0% |
| Q2 2026 | 96.1K | $3.76M | $39.12 | $966.1K | $631.4K | 0.0% |